Caplin Point attends TRINITY INDIA 2026 on May 28

0 min read     Updated on 23 May 2026, 06:24 AM
scanx
Reviewed by
Riya DScanX News Team
AI Summary

Caplin Point Laboratories Limited announced its participation in the 16th Annual Global Investor Conference TRINITY INDIA 2026 on May 28, 2026, in Mumbai. The company will engage with analysts and institutional investors through one-on-one and group meetings starting at 10.00 AM. The schedule is subject to change based on exigencies.

powered bylight_fuzz_icon
41011691

*this image is generated using AI for illustrative purposes only.

Caplin Point Laboratories Limited has announced its participation in the 16th Annual Global Investor Conference titled TRINITY INDIA 2026. The event is scheduled to take place on May 28, 2026, in Mumbai. The company will engage with various analysts and institutional investors during the conference.

The interaction will include both one-on-one and group meetings on a physical basis. The meeting is set to commence at 10.00 AM. The schedule is subject to changes based on exigencies concerning the analysts, institutional investors, or the company.

Meeting Details

Date, Time & Location Participant Interaction Type Meeting Type
May 28, 2026, Thursday, 10.00 AM at Mumbai Various Analyst/Institutional Investors One to one basis and Group Meeting Physical

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation was signed by Venkatram G, General Counsel & Company Secretary of Caplin Point Laboratories Limited.

Historical Stock Returns for Caplin Point Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
+2.46%+3.96%+18.57%+8.29%-9.20%+234.77%

What strategic updates or pipeline developments might Caplin Point Laboratories reveal to institutional investors at the TRINITY INDIA 2026 conference?

How could increased institutional investor interest following the conference impact Caplin Point Laboratories' stock liquidity and valuation multiples?

What expansion plans in emerging markets or new therapeutic segments is Caplin Point likely to highlight to attract fresh institutional capital?

Caplin Point Laboratories
View Company Insights
View All News
like17
dislike

Caplin Point Q4 FY26 Earnings Call Transcript Available

1 min read     Updated on 22 May 2026, 04:38 AM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Caplin Point Laboratories has announced the availability of the transcript for its earnings conference call regarding Q4 and FY2026 results. The call, held on May 14, 2026, discussed financial performance and business outlook, with both audio and transcript records now accessible online.

powered bylight_fuzz_icon
39710400

*this image is generated using AI for illustrative purposes only.

Caplin Point Laboratories has announced that the transcript of its earnings conference call for the quarter and year ended March 31, 2026, is now available on the company's official website. The call was originally held on Thursday, May 14, 2026, to discuss the financial performance for Q4 and FY2026. This update was communicated via a regulatory filing dated May 21, 2026, signed by Venkatram G, General Counsel & Company Secretary, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Transcript and Audio Access

The transcript of the earnings call has been uploaded to the company's website and can be accessed via the provided link. Additionally, the audio recording of the session remains available for investors, analysts, and fund houses who were unable to participate in the live event.

Earnings Conference Call Details

The conference call covered the company's financial results and business outlook. The following details were relevant to the event:

Parameter Details
Date Thursday, May 14, 2026
Time 16:30 hours IST
Financial Period Q4 and FY2026

Management Representatives

The management team represented Caplin Point Laboratories during the call, including the Chairman, Vice Chairman, Managing Director, Chief Financial Officer, and Deputy CFO.

Investor Relations Contact

For queries regarding the earnings conference call, participants may contact the designated investor relations representatives at Churchgate Partners or 360 One CM Research.

Historical Stock Returns for Caplin Point Laboratories

1 Day5 Days1 Month6 Months1 Year5 Years
+2.46%+3.96%+18.57%+8.29%-9.20%+234.77%

What key growth drivers or strategic initiatives did Caplin Point Laboratories' management highlight for FY2027 during the earnings call?

How did Caplin Point's FY2026 revenue and margin performance compare to its peers in the specialty pharma and emerging markets segment?

Are there any planned expansions into new geographies or therapeutic segments that could materially impact Caplin Point's revenue mix in the near term?

Caplin Point Laboratories
View Company Insights
View All News
like15
dislike

More News on Caplin Point Laboratories

1 Year Returns:-9.20%